ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "depression"

  • Abstract Number: 1558 • 2014 ACR/ARHP Annual Meeting

    Evaluation of Extreme Enthesitis and/or Patient-Related Outcome Score As Potential Surrogates for Fibromyalgia and As Potential Confounding Factors of Anti-TNF Response

    M Dougados1, H Jones2, A Szumski3, I Logeart4 and J Coindreau5, 1Université Paris René Descartes and Hôpital Cochin, Paris, France, 2Inflammation & Immunology, Pfizer Inc., Collegeville, PA, 3Pfizer Inc., Collegeville, PA, 4Pfizer, Paris, France, 5Pfizer Inc., New York, NY

    Background/Purpose: Differentiating between pain related to spondyloarthritis (in particular polyenthesitis) and pain related to fibromyalgia can be challenging, both in daily practice and in clinical…
  • Abstract Number: 1436 • 2014 ACR/ARHP Annual Meeting

    Impact of Depression on Clinical and Social Outcomes in Patients with Rheumatoid Arthritis: Comparative Study in Germany and Brazil

    Harriet Morf1, Olga Malysheva2, G da Rocha3, Anna Beatriz Vargas3 and Christoph G. Baerwald2, 1Department of Internal Medicine, University Hospital, Leipzig, Germany, 2Rheumatology, University Hospital, Leipzig, Germany, 3Ambulatório de reumatologia da Policlínica Piquet Carneiro, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    Background/Purpose Rheumatoid Arthritis (RA) can be associated with psychological disorders and especially depression. About 13 – 20 % of patients have clinical significant depression. It…
  • Abstract Number: 1363 • 2014 ACR/ARHP Annual Meeting

    Psychosocial Comorbidities Are Independently Associated with Subclinical Atherosclerosis in Rheumatoid Arthritis

    Ying Liu1, Moyses Szklo2, Karina Davidson3, Joan Bathon4 and Jon Giles3, 1Internal Medicine, Columbia University Medical Center, New York, NY, 2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 3Columbia University Medical Center, New York, NY, 4Medicine, Columbia University, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) is associated with higher rates of cardiovascular disease (CVD) and subclinical atherosclerosis as well as psychosocial comorbidities, which themselves are associated…
  • Abstract Number: 1339 • 2014 ACR/ARHP Annual Meeting

    Is Psychological Status Related to Symptom Experience in Behçet’s Syndrome?

    Robert Moots1 and Sophie Campbell2, 1Musculoskeletal Biology, University of Liverpool, Liverpool, United Kingdom, 2Behcets Centre, Aintree University Hospital, Liverpool, United Kingdom

    Background/Purpose Little is known about the impact of Behçet’s Syndrome (BS) within the UK.  The recent establishment of National Centres of Excellence now allows a…
  • Abstract Number: 1088 • 2013 ACR/ARHP Annual Meeting

    Fibromyalgia and Parental Medical Histories Of Depression and Alcoholism

    Robert S. Katz1, Ben J. Small2, Sharon M. Ferbert3 and Susan Shott4, 1Rush Medical College, Chicago, IL, 2Rush University Medical School, Chicago, IL, 3Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL, 4Rush University Medical Center, Chicago, IL

    Background/Purpose: We had found in a previous study suggestions of an increased prevalence of depression in the mothers and alcohol abuse in the fathers of…
  • Abstract Number: 1033 • 2013 ACR/ARHP Annual Meeting

    Psychological status correlates of disease activity and sleep quality in patients with Ankylosing Spondylitis: A case-control study

    Mingcan Yang1, Yutong Jiang2, Zhiming Lin3, Zetao Liao4, Qiuxia Li4, Yanli Zhang1 and Jieruo Gu5, 1Rheumatology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2Rheumatology, Third affiliated hospital of Sun Yat-sen University, Guangzhou, China, 3Rheumatology, third affiliated hospital of Sun Yat-sen Universtiy, Guangzhou, China, 4Rheumatology, The Affiliated Third Hospital of Sun Yat-san University, Rheumatology, Guangzhou, China, 5Medicine, Third Affiliated Hospital of Sun Yat-sen University, GuangZhou, China

    Background/Purpose: The objective of this study was to compare psychological status and sleep quality between the patients with AS patients and healthy controls, and to discover the correlation between anxiety, depression and sleep disturbances, to evaluate the associated factors of disease specific variables in AS patients and to detect independent factors contributing to psychological variables. Methods: A nationwide face-to-face epidemiological investigation was performed in multiple centers of China. The demographic data , clinical symptoms/signs and psychological assessment data including Zung self-rating anxiety scale (SAS), Zung self-rating depression scale (SDS) and the Pittsburgh Sleep Quality Index questionnaire (PSQI) were collected using questionnaires. Mann-Whitney U test and t test was used in independent groups for parametric variables, whereas the Spearman correlation analysis and multiple stepwise regression analysis were used to assess correlation between parametric variables.  Results: 683 AS patients by the revised New York criteria for AS and 697 age-, sex-, education-matched healthy controls were enrolled in the study.(1) Compared with healthy controls, AS patients suffered from more severe psychological disorders and sleep disturbance(P
  • Abstract Number: 1036 • 2013 ACR/ARHP Annual Meeting

    The Independent Impact Of Depression On Incident Myocardial Infarction In Psoriatic Disease: A Population-Based Cohort Study

    Lindsay C Burns1,2, Jan P. Dutz1 and Hyon Choi3,4,5, 1Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, 2Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 5Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Psoriasis (PsC) and psoriatic arthritis (PsA) represent common, lifelong inflammatory diseases of the skin and joints (respectively) that are associated with substantial cardiovascular and…
  • Abstract Number: L6 • 2013 ACR/ARHP Annual Meeting

    Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Co-Morbid Depression Receiving Concurrent Antidepressant Therapy: A Randomized, 2-Way Crossover, Double-Blind, Placebo-Controlled Study

    Lesley M. Arnold1, Piercarlo Sarzi-Puttini2, Pierre Arsenault3, Tahira Khan4, Pritha Bhadra Brown5, Andrew Clair5, Joseph Driscoll4, Jaren Landen4 and Lynne Pauer4, 1Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, 2Azienda Ospedaliera Polo Universitario L. Sacco, Milano, Italy, 3Département de Médecine de Famille, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Pfizer Inc, Groton, CT, 5Pfizer Inc, New York, NY

    Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain and often associated with mood disorders including depression. Approximately 50–70% of FM patients have a lifetime…
  • Abstract Number: 2716 • 2013 ACR/ARHP Annual Meeting

    Support For Psychological State May Be Effective to Attain Remission Of Boolean-Based Definition Of Patient Global Assessment In Patients With Rheumatoid Arthritis

    Mie Fusama1, Kumiko Yukioka2, Takanori Kuroiwa3, Chikako Yukioka4, Miyako Inoue2, Tae Nakanishi2, Norikazu Murata4, Noriko Takai5, Kayoko Higashi6, Taro Kuritani7, Keiji Maeda7, Yasushi Miura1, Hajime Sano8, Masao Yukioka4 and Hideko Nakahara9, 1Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Division of Clinical Psychology, Yukioka Hospital, Osaka, Japan, 3Department of Rheumatology, Yukioka Hospital, Osaka, Japan, 4Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan, 5Division of Clinical Psychology, Yukioka College of Health Science, Osaka, Japan, 6Division of nursing, NTT West Osaka Hospital, Osaka, Japan, 7Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan, 8Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya-city, Japan, 9Division of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan

    Background/Purpose: The patients with rheumatoid arthritis (RA) often do not meet patient global assessment (PGA) remission criterion despite a good clinical disease state and, therefore,…
  • Abstract Number: 2446 • 2013 ACR/ARHP Annual Meeting

    Opiate Use In Patients With Ankylosing Spondylitis

    John D. Reveille1, Michael M. Ward2, MinJae Lee3, Mohammad Rahbar4, Manouchehr Ardjomand-Hessabi5, Laura A. Diekman5, Matthew A. Brown6, Lianne S. Gensler7 and Michael H. Weisman8, 1Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 2Bldg 10 CRC Rm 4-1339, NIAMS/NIH, Bethesda, MD, 3Medicine, University of Texas Health Science Center at Houston, Houston, TX, 4The University of Texas Health Science Center at Houston, Houston, TX, 5Rheumatology, The University of Texas Health Science Center at Houston, Houston, TX, 6Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, Australia, 7Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 8Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Prescription opiates are commonly prescribed in patients with chronic pain, yet there is no evidence that these drugs ameliorate disease progression, and are associated with numerous…
  • Abstract Number: 2297 • 2013 ACR/ARHP Annual Meeting

    Evaluating Depression Questionnaires In German Rheumatoid Arthritis Patients – Preliminary Results From a Validation Study

    Matthias Englbrecht1, Rieke Alten2, Martin Aringer3, Christoph G. Baerwald4, Harald Burkhardt5, Nancy Eby6, Gerhard Fliedner7, Bettina Gauger8, Ulf Henkemeier9, Michael Hofmann10, Stefan Kleinert11, Christian Kneitz12, Christoph Pohl13, Georg Schett1, Marc Schmalzing14, Anne-Kathrin Tausche15, Hans Peter Tony16 and Joerg Wendler17, 1Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Teaching Hospital of the Charité, University of Berlin, Berlin, Germany, 3Rheumatology, Medicine III, University Clinical Center Technical University of Dresden, Dresden, Germany, 4Rheumatology, University Hospital, Leipzig, Germany, 5CIRI /Div. of Rheumatology, Goethe-University, Frankfurt/Main, Germany, 6Biostatistics, AMS-Advanced Medical Services, Mannheim, Germany, 7Praxis Osnabrück, Germany, Germany, Osnabrück, Germany, 8Roche Pharma AG, Grenzach, Germany, 9University Hospital Frankfurt, Frankfurt, Germany, 10Chugai Pharma, Frankfurt, Germany, 11Rheumatology/Clinical Immunology,, University Hospital Würzburg, Würzburg, Germany, 12Internal Medicine II, Hospital Südstadt, Rostock, Germany, 13Rheumatology,Clinical Immunolo, Schlosspark Klinik, Berlin, Germany, 14Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, Germany, 15Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany, 16Rheumatology/Immunology, University of Würzburg, Würzburg, Germany, 17Schwerpunktpraxis Rheumatologie, Erlangen, Germany

    Background/Purpose: To date, only a few studies have discussed the prevalence of depression in RA patients in Germany and depression questionnaires have not been validated…
  • Abstract Number: 1103 • 2013 ACR/ARHP Annual Meeting

    Brain Derived Neurotrophic Factor Is Elevated In Patients With Rheumatoid Arthritis and Secondary Fibromyalgia

    Able Lawrence, Venkatesh Pai, Rajni Srivastava, Vikas Agarwal, Ramnath Misra and Amita Aggarwal, Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose: Secondary Fibromyalgia is seen in 15% of patients with rheumatoid arthritis (RA). Neurotrophins are elevated in patients with active arthritis and BDNF is elevated…
  • Abstract Number: 1097 • 2013 ACR/ARHP Annual Meeting

    A Potential Use Of NeurotropinTM, a Novel Neuro-Modulating Medication, For The Treatment Of Chronic Pain and Fibromyalgia

    Kenji Miki1,2,3, Ryota Hashimoto4,5,6, Kenrin Shi2,7,8 and Masao Yukioka8, 1Department of Orthopaedic Surgery, Amagasaki Central Hospital, Amagasaki, Japan, 2Center for Pain Management, Osaka University Hospital, Suita, Japan, 3Dept. of Rheumatology, Yukioka Hospital, Osaka, Japan, 4Dept of Rheumatology, Yukioka Hospital, Osaka, Japan, 5Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan, 6Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Suita, Japan, 7Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Japan, 8Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan

    Background/Purpose: To date, no established treatment for chronic pain including fibromyalgia has been specified in Japan. Neurotropin, a non-protein extract isolated from the inflamed cutaneous…
  • Abstract Number: 1104 • 2013 ACR/ARHP Annual Meeting

    Quality Of Life and Burden Of Ehlers-Danlos Syndrome (EDS) Type III

    Marion Geoffroy1, Christelle Guillaume1, Amélie Servettaz1, Violaine Laurant-Noel1, Christine Serratrice Sr.2, Jacques Serratrice3, Boris Bienvenu4 and Roland Jaussaud5, 1Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré. CHU de Reims, Reims, France, 2internal medicine, Foundation Hopital Saint Joseph, Marseille, France, 3Hôpital de la Timone, Marseille, France, 4Division of Internal Medicine, Centre Hospitalier Régional Universitaire de Caen, Côte de Nacre, Caen, France, Caen, France, 5Médecine interne, maladies infectieuses, immunologie clinique, CHU de Reims, REIMS, France

    Background/Purpose: The Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of inherited connective tissue disorders. Hypermobility type EDS is the most common type…
  • Abstract Number: 1073 • 2013 ACR/ARHP Annual Meeting

    Longitudinal Decline In Steps/Day In Older Adults With Or At High Risk Of Knee OA

    Daniel K. White1, Roger Fielding2, K. Douglas Gross3, Michael C. Nevitt4, Cora E. Lewis5, James Torner6 and Tuhina Neogi7, 1Boston University School of Medicine, Boston, MA, 2Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, 3Physical Therapy, MGH Institute of Health Professions, Boston, MA, 4Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 5Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, 6Epidemiology, University of Iowa, Iowa City, Iowa City, IA, 7Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Walking is the most common type of physical activity older adults employ for physical activity, which, when performed regularly, confers important health benefits.  When…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology